← Evidence map

ArticleCell communication and signaling : CCS2019

Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1-mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma.

Sarita Saraswati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

35 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 31619257